D.E. Shaw & Co’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-205,535
Closed -$417K 3699
2016
Q1
$417K Buy
205,535
+35,814
+21% +$63.9K ﹤0.01% 2872
2015
Q4
$421K Buy
169,721
+82,868
+95% +$246K ﹤0.01% 3181
2015
Q3
$226K Sell
86,853
-12,200
-12% -$31.8K ﹤0.01% 3458
2015
Q2
$311K Sell
99,053
-129,896
-57% -$445K ﹤0.01% 3397
2015
Q1
$655K Buy
228,949
+98,617
+76% +$252K ﹤0.01% 2890
2014
Q4
$336K Buy
+130,332
New +$570K ﹤0.01% 3588
2014
Q2
Sell
-17,194
Closed -$200K 4803
2014
Q1
$200K Buy
+17,194
New +$202K ﹤0.01% 4085

D.E. Shaw & Co's SZYM Position: Q2 2016 in Review

D.E. Shaw & Co sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 205,535 shares — an estimated $417K sold.

D.E. Shaw & Co first reported a position in SZYM in Q1 2014 and held it in 7 quarters. The position peaked at $655K in Q1 2015. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • D.E. Shaw & Co reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • D.E. Shaw & Co sold 205,535 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $417K.
  • D.E. Shaw & Co first reported a position in SOLAZYME INC COM STK (DE) in Q1 2014 and held it in 7 quarters.
  • D.E. Shaw & Co's SOLAZYME INC COM STK (DE) position peaked at $655K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on D.E. Shaw & Co's 13F filing for Q2 2016, filed 15 Aug 2016.